Market cap
$12.5bn
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
Arrowhead is also eligible to receive development, regulatory, and sales milestone payments of up to $975 million. Additionally, the Company is eligible to receive up to $2.0 billion in potential milestone payments plus royalties on commercial sales. RESULTS OF OPERATIONS The following data summarizes the Company’s results of operations for the following periods indicated: Revenue Total revenue for the three and nine months ended June 30, 2026 increased by $47.5 million and decreased by $160.0 million, respectively, as compared to the same periods of 2025. …ARROWHEAD PHARMACEUTICALS, INC., 10-Q, period ended 2026-06-30, filed 2026-08-04